CYA

(redirected from Cyclosporine A)
Also found in: Dictionary, Medical.
AcronymDefinition
CYASee You
CYACover Your Ass
CYACanadian Yachting Association
CYAChantilly Youth Association (Chantilly, VA)
CYACalifornia Youth Authority
CYACover Your Assets
CYACollege Year in Athens (Greece; study abroad program)
CYACyclosporine A (immunosuppressant)
CYACyanuric Acid
CYACy Young Award (ML Baseball Award for Pitching)
CYAChange Your Attitude
CYACollege/Young Adult (ministry)
CYACarry Your Ass
CYACumbria Youth Alliance (UK)
CYAClassic Yacht Association
CYACover Your Answer(s)
CYACall Your Attorney
CYACuban Yoga Association
CYACarclew Youth Arts (Australia)
CYACanadian Youth Assembly (est. 2008)
CYACan You Articulate
CYAChristian Youth Association
CYAChallenge Your Assumptions
CYACatch You Afterwards
CYACompany of Young Artists (Youth Musical Theater Group, Fullerton College, CA)
CYACommittee of Young Artists (Mississauga Arts Council)
References in periodicals archive ?
Reformulating cyclosporine A (CsA): More than just a life cycle management strategy.
Group B was given Cyclosporine A, 20 mg/kg dissolved in 2 ml of olive oil intraperitoneally for 7 days.
Consequently, the aim of the present study was to evaluate the effect of Spinacea oleracea on histological structure of rat kidney treated with cyclosporine A.
Efficacy of combined cyclosporine A and ketoconazole treatment of anal furunculosis.
Antioxidant nutrients protect against cyclosporine a nephrotoxicity.
Eckstein's presentation will discuss Enanta's most recent cyclosporine research that includes the development of new cyclosporine analogs, EP-314 and EP-012637, which, when converted into non-toxic metabolites, prove to be distinct from Cyclosporine A and its metabolites that have limited therapeutic potential due to kidney toxicity.
of San Diego, and cyclosporine A (CsA) as a new therapeutic approach to prevent rejection of transplanted organs.
Subsequently, investigations comparing sirolimus versus cyclosporine as a base therapy for immunosuppression have been undertaken with similar outcomes in patient survival, kidney graft survival, and incidence of rejection being reported (Groth et al.
More evidence is needed before recommending the routine use of cyclosporine as an alternative to corticosteroids.
He continued, "Subject to providing satisfactory responses to all questions the FDA may have, we look forward to receiving US market clearance for CYCLOSPORINE as a bioequivalent product to Neoral and launch.